Trials · 2018 · 28 citations · 19 references
MedicineClinical SciencesPediatricsInfant HealthNeonatologyVentilationBronchopulmonary DysplasiaContinuous Positive Airway PressureMechanical VentilationNeonatal Intensive CareNeonatal VentilationRespiratory Distress SyndromeInfant Respiratory SupportMechanical Ventilation In NewbornsNasal Continuous Positive Airway PressureNeonatal High-frequency VentilationNeonatal Mechanical VentilationNeonatal Respiratory Distress SyndromeRespiratory Distress Syndrome VentilationRespiratory Outcomes In Prematurity
BACKGROUND: Invasive mechanical ventilation (IMV) is associated with the development of adverse pulmonary and non-pulmonary outcomes in very premature infants. Various modes of non-invasive respiratory support are increasingly being used to decrease the incidence of bronchopulmonary dysplasia. The aim of this trial is to compare the effect of non-invasive high-frequency oscillatory ventilation (NHFOV) and nasal continuous positive airway pressure (NCPAP) in preterm infants with respiratory distress syndrome (RDS) as a primary non-invasive ventilation support mode. METHODS/DESIGN: weeks with a diagnosis of RDS will be randomized to NHFOV or NCPAP as a primary mode of non-invasive respiratory support. The study will be conducted in 18 tertiary neonatal intensive care units in China. The primary outcome is the need for IMV during the first 7 days after enrollment in preterm infants randomized to the two groups. The prespecified secondary outcomes include days of hospitalization, days on non-invasive respiratory support, days on IMV, days on supplemental oxygen, mortality, need for a surfactant, severe retinopathy of prematurity requiring laser treatment or surgery, patent ductus arteriosus needing ligation, bronchopulmonary dysplasia, abdominal distention, air leak syndromes, intraventricular hemorrhage (≥ grade 3), spontaneous intestinal perforation, necrotizing enterocolitis (≥II stage), and nasal trauma. Other secondary outcomes include Bayley Scales of Infant Development at 18-24 months of corrected age. DISCUSSION: In recent decades, several observational studies have compared the effects of NHFOV and NCPAP in neonates as a rescue mode or during weaning from IMV. To our knowledge, this will be the first multi-center prospective, randomized controlled trial to evaluate NHFOV as a primary mode in preterm infants with RDS in China or any other part of the world. Our trial may help to establish guidelines for NHFOV in preterm infants with RDS to minimize the need for IMV, and to decrease the significant pulmonary and non-pulmonary morbidities associated with IMV. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03099694 . Registered on 4 April 2017.
19
Alan H. Jobe, Eduardo Bancalari · American Journal of Respiratory and Critical Care Medicine · 2001 · 4.8K citations
Medicine, Child Health, Pediatrics +15
Neonatal Necrotizing Enterocolitis
Martin Bell, Jessie L. Ternberg, Ralph D. Feigin et al. · Annals of Surgery · 1978 · 3.5K citations · Full text
Medicine, Microbiology, Pediatrics +12
European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2016 Update
David G. Sweet, Virgilio Carnielli, Gorm Greisen et al. · Neonatology · 2016 · 736 citations · Full text
Medicine, Obstetrics, Pediatrics +17